Concepedia

Takuma Shikata

TS

Statistics

Publications

8

Citations

721

H-Index

8

Active since

1991

Affiliations

Kyoto Prefectural University of Medicine(Current)

St. Jude Children's Research Hospital

Takuma Shikata is an author at Kyoto Prefectural University of Medicine specializing in medicine, oncology, and molecular oncology.

Publications per year

1991–2001

8

Publications

8

Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.

Hajime Hosoi, Michael B. Dilling, Takuma Shikata et al. · PubMed · 1999 · 316 citations

, , +17

Studies on the Mechanism of Resistance to Rapamycin in Human Cancer Cells

Hajime Hosoi, Michael B. Dilling, Linda N. Liu et al. · Molecular Pharmacology · 1998 · 172 citations

, , +16

p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.

Shile Huang, Linda N. Liu, Hajime Hosoi et al. · PubMed · 2001 · 132 citations

, , +17

N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells.

Akiko Misawa, Hajime Hosoi, A Arimoto et al. · PubMed · 2000 · 43 citations

, , +17

Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line.

Tetsuya Yasuno, Takafumi Matsumura, Takuma Shikata et al. · PubMed · 2000 · 20 citations

, , +14

1–5 of 8